Showing results (551-560 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|June 25, 2013
Chromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17, and LPIN2 genesAnkit Malhotra, Yoshiyuki Shibata, Ira M Hall, et al.Cancer Biology & Therapy|June 25, 2013
Cables1 is a tumor suppressor gene that regulates intestinal tumor progression in Apc(Min) miceThomas Arnason, Maria S Pino, Omer Yilmaz, et al.Cancer Biology & Therapy|June 25, 2013
Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancerChandra P Belani, John J Nemunaitis, Abraham Chachoua, et al.Cancer Biology & Therapy|June 25, 2013
Bimodal role of Kupffer cells during colorectal cancer liver metastasisShu Wen Wen, Eleanor I Ager, Christopher ChristophiCancer Biology & Therapy|June 25, 2013
A CDK4/6 inhibitor enhances cytotoxicity of paclitaxel in lung adenocarcinoma cells harboring mutant KRAS as well as wild-type KRASXiang-Hua Zhang, Ying Cheng, Jung-Young Shin, et al.Cancer Biology & Therapy|June 25, 2013
Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cellsDimitra Florou, Christos Patsis, Alexandros Ardavanis, et al.Cancer Biology & Therapy|June 7, 2012
Selenium-containing histone deacetylase inhibitors for melanoma managementRaghavendra Gowda, Subbarao V Madhunapantula, Dhimant Desai, et al.Cancer Biology & Therapy|November 30, 2012
A molecular case report: functional assay of tyrosine kinase inhibitors in cells from a patient's primary renal cell carcinomaMolly F Kulesz-Martin, James Lagowski, Susan Olson, et al.Cancer Biology & Therapy|November 30, 2012
Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cellsLan Coffman, Collin Mooney, Jaeyoung Lim, et al.Cancer Biology & Therapy|November 30, 2012
Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosisAna Slipicevic, Geir Frode Øy, Anne Katrine Ree Rosnes, et al.Pageof 387